173 related articles for article (PubMed ID: 2397608)
1. Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis.
Famularo G; Procopio A; Giacomelli R; Danese C; Sacchetti S; Perego MA; Santoni A; Tonietti G
Clin Exp Immunol; 1990 Sep; 81(3):368-72. PubMed ID: 2397608
[TBL] [Abstract][Full Text] [Related]
2. Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1 alpha, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies.
Mantovani G; Macciò A; Lai P; Ghiani M; Turnu E; Del Giacco GS
Cell Biophys; 1995 Aug; 27(1):1-14. PubMed ID: 7493395
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
Fagiolo E; Abenante L
Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
[TBL] [Abstract][Full Text] [Related]
4. Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease.
Damle RN; Advani SH; Gangal SG
Int J Cancer; 1992 Jan; 50(2):192-6. PubMed ID: 1730512
[TBL] [Abstract][Full Text] [Related]
5. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
6. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
Steen VD; Engel EE; Charley MR; Medsger TA
J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
[TBL] [Abstract][Full Text] [Related]
7. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
[TBL] [Abstract][Full Text] [Related]
8. Alteration of interleukin-2 (IL-2) and soluble IL-2 receptor secretion in the sera and urine of patients with rickettsial boutonneuse fever.
Mansueto S; D'Ancona FP; Colletti P; Graceffa R; La Seta F; Pecoraro V; Gambino G; Grillo G; Vitale G; Richiusa P; D'Agostino P; Cillari E
J Infect Dis; 1997 Jan; 175(1):142-5. PubMed ID: 8985208
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 production by mononuclear cells from patients with scleroderma.
Sandborg CI; Berman MA; Andrews BS; Friou GJ
Clin Exp Immunol; 1985 May; 60(2):294-302. PubMed ID: 3874022
[TBL] [Abstract][Full Text] [Related]
10. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
Symons JA; Wood NC; Di Giovine FS; Duff GW
J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
[TBL] [Abstract][Full Text] [Related]
11. Effect of luteinizing hormone alpha-subunit on IL-2 and sIL-2R in vitro secretions from human peripheral blood mononuclear cells.
Komorowski J; Gradowski G; Stepień H
Cytobios; 1997; 89(356):31-7. PubMed ID: 9297814
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor release defect in vitro in elderly subjects.
Caruso C; Di Lorenzo G; Modica MA; Candore G; Portelli MR; Crescimanno G; Ingrassia A; Sangiorgi GB; Salerno A
Mech Ageing Dev; 1991 Jun; 59(1-2):27-35. PubMed ID: 1890884
[TBL] [Abstract][Full Text] [Related]
13. Soluble intercellular adhesion molecule-1 (sICAM-1) and soluble interleukin-2 receptors (sIL-2R) in scleroderma skin.
Søndergaard K; Stengaard-Pedersen K; Zachariae H; Heickendorff L; Deleuran M; Deleuran B
Br J Rheumatol; 1998 Mar; 37(3):304-10. PubMed ID: 9566672
[TBL] [Abstract][Full Text] [Related]
14. Circulating interleukin 1 beta and soluble interleukin 2 receptor: evaluation as markers of disease activity in scleroderma.
Patrick MR; Kirkham BW; Graham M; Harrision LC
J Rheumatol; 1995 Apr; 22(4):654-8. PubMed ID: 7791158
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.
Gooding R; Riches P; Dadian G; Moore J; Gore M
Br J Cancer; 1995 Aug; 72(2):452-5. PubMed ID: 7640231
[TBL] [Abstract][Full Text] [Related]
16. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.
Chatenoud L; Dugas B; Beaurain G; Touam M; Drueke T; Vasquez A; Galanaud P; Bach JF; Delfraissy JF
Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7457-61. PubMed ID: 3094009
[TBL] [Abstract][Full Text] [Related]
17. Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.
Mantovani G; Macciò A; Astara G; Contini L; Esu S; Littera S; Arangino V; Lai P; Proto E; Pusceddu G
Cell Biophys; 1993; 22(1-3):79-99. PubMed ID: 7889544
[TBL] [Abstract][Full Text] [Related]
18. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
[TBL] [Abstract][Full Text] [Related]
19. IL-15 induces the release of soluble IL-2Ralpha from human peripheral blood mononuclear cells.
Treiber-Held S; Stewart DM; Kurman CC; Nelson DL
Clin Immunol Immunopathol; 1996 Apr; 79(1):71-8. PubMed ID: 8612353
[TBL] [Abstract][Full Text] [Related]
20. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
Duan ZF
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]